Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.

Columnist Kristin Neva and her husband, Todd, have discovered wheelchair upgrades that would improve their life with ALS.

Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight ...

Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

Woolsey Pharmaceuticals has secured additional funds to continue advancing its ROCK inhibitor Bravyl (oral fasudil) for the ...

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

With the scheduled end to Medicare's telehealth coverage, columnist Kristin Neva and her husband are advocating for their benefits.

Fat molecules known as PUFAs can help lessen nerve damage in amyotrophic lateral sclerosis (ALS), a study suggests.

Health regulators in Canada gave conditionally approval to Qalsody to treat adults whose ALS is due to mutations in the SOD1 ...

Measuring blood levels of NfL, a biomarker of nerve damage, could help diagnose ALS and predict the risk of death for ...